AIM2 deletion enhances blood‐brain barrier integrity in experimental ischemic stroke

AIMS: Ischemic stroke is a life‐threatening disease with limited therapeutic strategies. Blood‐brain barrier (BBB) disruption is a critical pathological process that contributes to poor outcomes in ischemic stroke. We previously showed that the microglial inhibition of the inflammasome sensor absent...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Si‐yi, Bian, Hui‐jie, Shu, Shu, Xia, Sheng‐nan, Gu, Yue, Zhang, Mei‐juan, Xu, Yun, Cao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446221/
https://www.ncbi.nlm.nih.gov/pubmed/34156153
http://dx.doi.org/10.1111/cns.13699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446221/
https://www.ncbi.nlm.nih.gov/pubmed/34156153
http://dx.doi.org/10.1111/cns.13699

Ejemplares similares